Inogen | INGN - Capital Ordinaire





Capital Ordinaire Changement Date
Abbott USD 1.74B 2.94M 2026-03
Accuray USD 100K 1000 2024-09
AngioDynamics USD 41.57M 127K 2025-09
Artivion USD 47.84M 468K 2025-12
AtriCure USD 50.64M 7K 2026-06
Baxter International USD 517M 549K 2026-06
Becton, Dickinson and Co. USD 272.39M 98.21M 2026-09
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 190.1M 5.01M 2026-06
Dexcom USD 377.4M 8.5M 2026-06
Edwards Lifesciences USD 576.6M 400K 2026-06
Globus Medical USD 132.66M 1.59M 2026-09
Inogen USD 23K 0 2023-12
Insulet USD 69.37M 16K 2026-09
Medtronic USD 1.28B 130K 2026-06
Orthofix International USD 39.83M 315K 2025-12
Philips EUR 977.61M 186K 2026-09
ResMed USD 145.06M 45.78M 2026-06
Steris USD 97.5M 575K 2026-09
Stryker USD 383.4M 416K 2026-06
Tandem Diabetes Care USD 69.76M 217K 2026-09
Teleflex USD 42.37M 1.89M 2026-06
X T L Biopharmaceuticals USD 946.24M 64.86M 2025-12
Zimmer Biomet Holdings USD 190.1M 3.3M 2026-09